Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bmab 1200 vs Stelara in Moderate to Severe Chronic Plaque Psoriasis
NCT05335356Phase 3Completed
- Sponsor
- Biocon
- Start
- Jun 2022
- Primary completion
- Jan 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of Starjemza in plaque psoriasis, sponsored by Biocon. Started Jun 2022; status: completed.
02
Drugs
Starjemza
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT05335356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05335356.